Rocket Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RCKT and other ETFs, options, and stocks.About RCKT
Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. Its multi-platform development approach applies the lentiviral vector and adeno-associated viral vector gene therapy platforms.
CEOGaurav D. Shah
CEOGaurav D. Shah
Employees299
Employees299
HeadquartersCranbury, New Jersey
HeadquartersCranbury, New Jersey
Founded1999
Founded1999
Employees299
Employees299
RCKT Key Statistics
Market cap380.40M
Market cap380.40M
Price-Earnings ratio-1.53
Price-Earnings ratio-1.53
Dividend yield—
Dividend yield—
Average volume2.46M
Average volume2.46M
High today$3.59
High today$3.59
Low today$3.46
Low today$3.46
Open price$3.50
Open price$3.50
Volume860.14K
Volume860.14K
52 Week high$13.35
52 Week high$13.35
52 Week low$2.19
52 Week low$2.19
Stock Snapshot
Rocket Pharmaceuticals(RCKT) stock is priced at $3.55, giving the company a market capitalization of 380.4M. It carries a P/E multiple of -1.53.
On 2025-12-24, Rocket Pharmaceuticals(RCKT) stock moved within a range of $3.46 to $3.59. With shares now at $3.55, the stock is trading +2.6% above its intraday low and -1.1% below the session's peak.
Trading activity shows a volume of 860.14K, compared to an average daily volume of 2.46M.
The stock's 52-week range extends from a low of $2.19 to a high of $13.35.
The stock's 52-week range extends from a low of $2.19 to a high of $13.35.
Analyst ratings
47%
of 15 ratingsBuy
46.7%
Hold
40%
Sell
13.3%
People also own
Based on the portfolios of people who own RCKT. This list is generated using Robinhood data, and it’s not a recommendation.